Skip to main content
. 2022 Jul 8;21:128. doi: 10.1186/s12933-022-01563-z

Table 1.

Baseline characteristics of ICU patients grouped according to TyG index quartiles

Categories Overall (N = 3026) Q1 (N = 756) Q2 (N = 755) Q3 (N = 758) Q4 (N = 757) P-value
Demographic
 Age, years, mean (SD) 65.44 (16.07) 68.32 (16.44) 66.83 (15.90) 65.62 (15.58) 60.99 (15.45) < 0.001
 Male, n (%) 1786 (59.0) 451 (59.7) 437 (57.9) 455 (60.0) 443 (58.5) 0.819
 Ethnicity, n (%) 0.003
  Asian 617 (20.4) 135 (17.9) 139 (18.4) 170 (22.4) 173 (22.9)
  Black 58 (1.9) 21 (2.8) 10 (1.3) 19 (2.5) 8 (1.1)
  White 202 (6.7) 62 (8.2) 44 (5.8) 36 (4.7) 60 (7.9)
  Hispanic/Latino 83 (2.7) 15 (2.0) 25 (3.3) 21 (2.8) 22 (2.9)
  Other 2066 (68.3) 523 (69.2) 537 (71.1) 512 (67.5) 494 (65.3)
 Weight, kg, mean (SD) 82.25 (22.71) 77.00 (19.72) 80.49 (22.39) 82.28 (21.75) 88.98 (24.93) < 0.001
 Height, cm, mean (SD) 169.92 (14.47) 171.03 (20.16) 169.30 (13.36) 169.27 (12.04) 170.14 (11.20) 0.319
 BMI, kg/m2, mean (SD) 31.35 (76.35) 36.20 (156.02) 29.21 (12.59) 29.18 (13.20) 31.10 (12.03) 0.581
ICU admission
 SOFA score, mean (SD) 3.32 (2.91) 2.86 (2.45) 3.00 (2.59) 3.42 (2.88) 4.01 (3.48) < 0.001
 LODS score, mean (SD) 3.49 (2.56) 3.08 (2.25) 3.20 (2.26) 3.64 (2.61) 4.05 (2.94) < 0.001
 OASIS score, mean (SD) 30.94 (8.96) 29.81 (8.58) 30.45 (8.38) 31.29 (9.04) 32.22 (9.61) < 0.001
 SIRS score, mean (SD) 2.51 (1.06) 2.32 (1.04) 2.40 (1.06) 2.57 (1.03) 2.73 (1.05) < 0.001
 APSIII, mean (SD) 39.29 (18.74) 36.61 (16.12) 37.10 (17.36) 39.37 (19.18) 44.05 (21.01) < 0.001
 SAPSII, mean (SD) 32.83 (13.23) 31.50 (12.09) 32.08 (12.33) 33.39 (13.59) 34.37 (14.58) < 0.001
 First Care Unit, n (%) < 0.001
  CCU 1259 (41.6) 332 (43.9) 304 (40.3) 333 (43.9) 290 (38.3)
  CSRU 152 (5.0) 27 (3.6) 36 (4.8) 45 (5.9) 44 (5.8)
  MICU 708 (23.4) 152 (20.1) 162 (21.5) 159 (21.0) 235 (31.0)
  SICU 643 (21.2) 180 (23.8) 176 (23.3) 154 (20.3) 133 (17.6)
  TSICU 264 (8.7) 65 (8.6) 77 (10.2) 67 (8.8) 55 (7.3)
Vital signs
 HR, bmp, mean (SD) 81.13 (16.20) 78.03 (15.21) 79.34 (15.65) 82.02 (15.79) 85.15 (17.18) < 0.001
 SBP, mmHg, mean (SD) 123.12 (18.63) 122.37 (18.77) 123.36 (18.51) 123.58 (19.21) 123.17 (18.03) 0.612
 DBP, mmHg, mean (SD) 63.82 (11.43) 63.21 (10.93) 63.78 (11.51) 64.17 (11.50) 64.14 (11.76) 0.321
 SpO2, %, mean (SD) 97.27 (2.02) 97.35 (1.65) 97.28 (1.83) 97.28 (2.26) 97.18 (2.26) 0.435
Comorbidities
 CHD, n (%) 1618 (53.5) 403 (53.3) 384 (50.9) 434 (57.3) 397 (52.4) 0.080
 HF, n (%) 879 (29.0) 216 (28.6) 209 (27.7) 218 (28.8) 236 (31.2) 0.483
 Hypertension, n (%) 1611 (53.2) 386 (51.1) 424 (56.2) 408 (53.8) 393 (51.9) 0.198
 AF, n (%) 724 (23.9) 207 (27.4) 186 (24.6) 182 (24.0) 149 (19.7) 0.005
 Dyslipidemia, n (%) 689 (22.8) 153 (20.2) 176 (23.3) 175 (23.1) 185 (24.4) 0.248
 DM, n (%) 828 (27.4) 68 (9.0) 135 (17.9) 235 (31.0) 390 (51.5) < 0.001
 COPD, n (%) 45 (1.5) 8 (1.1) 5 (0.7) 16 (2.1) 16 (2.1) 0.037
 RF, n (%) 481 (15.9) 73 (9.7) 96 (12.7) 135 (17.8) 177 (23.4) < 0.001
 LD, n (%) 143 (4.7) 21 (2.8) 36 (4.8) 39 (5.1) 47 (6.2) 0.016
 AKIa, n (%) 1547 (51.1) 345 (45.6) 345 (45.7) 412 (54.4) 445 (58.8) < 0.001
 CKD, n (%) 310 (10.2) 71 (9.4) 58 (7.7) 75 (9.9) 106 (14.0) 0.001
 Sepsis, n (%) 162 (5.4) 24 (3.2) 32 (4.2) 40 (5.3) 66 (8.7) < 0.001
 Cancer, n (%) 360 (11.9) 98 (13.0) 103 (13.6) 88 (11.6) 71 (9.4) 0.054
Laboratory tests
 WBC, K/µL, mean (SD) 11.75 (5.88) 10.65 (4.75) 11.50 (6.86) 12.01 (5.29) 12.85 (6.18) < 0.001
 RBC, m/µL, mean (SD) 4.19 (0.73) 4.17 (0.68) 4.21 (0.71) 4.17 (0.75) 4.20 (0.78) 0.568
 Platelet, K/µL, mean (SD) 252.91 (110.48) 245.85 (110.86) 254.08 (109.33) 255.96 (109.13) 255.75 (112.49) 0.236
 Hemoglobin, g/dL, mean (SD) 12.69 (2.15) 12.69 (2.00) 12.77 (2.15) 12.64 (2.22) 12.67 (2.24) 0.645
 Serum potassium, mEq/L, mean (SD) 4.20 (0.81) 4.19 (0.82) 4.18 (0.78) 4.16 (0.72) 4.29 (0.89) 0.007
 Serum sodium, mEq/L, mean (SD) 138.43 (4.58) 138.30 (4.74) 138.69 (4.29) 138.57 (4.13) 138.15 (5.10) 0.084
 TC, mg/dL, mean (SD) 163.17 (54.46) 151.66 (42.60) 160.83 (46.99) 165.97 (47.13) 175.50 (74.60) < 0.001
 TG, mg/dL, mean (SD) 143.99 (168.28) 66.55 (21.27) 104.21 (74.80) 138.64 (48.33) 266.35 (286.95) < 0.001
 LDL, mg/dL, mean (SD) 91.57 (40.10) 86.06 (35.61) 94.04 (40.53) 95.14 (40.98) 91.17 (42.83) < 0.001
 HDL, mg/dL, mean (SD) 45.78 (16.71) 52.62 (18.01) 46.43 (14.84) 43.82 (14.89) 39.42 (16.10) < 0.001
 HbA1c, %, mean (SD) 6.43 (1.59) 5.86 (0.82) 5.97 (0.79) 6.31 (1.27) 7.63 (2.32) < 0.001
 Glucose, mg/dL, mean (SD) 162.37 (105.57) 128.03 (45.85) 138.73 (47.71) 159.99 (77.66) 222.79 (169.83) < 0.001
 Albumin, g/dL, mean (SD) 3.43 (0.64) 3.49 (0.59) 3.47 (0.65) 3.40 (0.63) 3.38 (0.67) 0.013
 Ucr, mg/dL, mean (SD) 97.90 (71.45) 93.62 (67.53) 100.90 (66.69) 100.79 (76.90) 96.48 (72.77) 0.745
 Scr, mg/dL, mean (SD) 1.30 (1.24) 1.19 (1.06) 1.19 (1.09) 1.29 (1.31) 1.51 (1.45) < 0.001
 BUN, mg/dL, mean (SD) 24.31 (17.61) 21.94 (12.78) 22.66 (17.55) 24.74 (16.94) 27.91 (21.49) < 0.001
 Uric acid, mg/dL, mean (SD) 5.66 (2.86) 5.74 (2.89) 4.93 (1.90) 5.58 (3.05) 6.01 (3.10) 0.377
 TyG index, mean (SD) 9.16 (0.74) 8.30 (0.33) 8.87 (0.12) 9.32 (0.15) 10.13 (0.49) < 0.001
Events
 LOS ICU, days, mean (SD) 4.28 (6.08) 3.68 (6.38) 3.78 (5.35) 4.16 (4.95) 5.49 (7.21) < 0.001
 LOS Hospital, days, mean (SD) 8.71 (10.12) 7.68 (8.71) 7.83 (8.58) 8.82 (9.71) 10.50 (12.68) < 0.001
 ICU death, n (%) 258 (8.5) 42 (5.6) 59 (7.8) 77 (10.2) 80 (10.6) 0.001
 Hospital death, n (%) 350 (11.6) 57 (7.5) 85 (11.3) 102 (13.5) 106 (14.0) < 0.001
 Follow-up death, n (%) 1148 (37.9) 265 (35.1) 270 (35.8) 306 (40.4) 307 (40.6) 0.040

TyG index: Q1 (6.23–8.65), Q2 (8.65–9.08), Q3 (9.08–9.59), Q4 (9.59–12.43)

TyG index triglyceride glucose index, BMI body mass index, ICU intensive care unit, SOFA sequential organ failure assessment, LODS logistic organ dysfunction system, OASIS Oxford acute severity of illness, SIRS systemic inflammatory response syndrome, APSIII acute physiology score III, SAPSII simplified acute physiological score II, CCU coronary care unit, CSRU cardiac surgery recovery unit, MICU medical intensive care unit, SICU surgical intensive care unit, TSICU trauma/surgical intensive care unit, HR heart rate, bmp beats per minute, SBP systolic blood pressure, DBP diastolic blood pressure, SpO2 pulse blood oxygen saturation, CHD coronary heart disease, HF heart failure, AF atrial fibrillation, DM diabetes mellitus, COPD chronic obstructive pulmonary disease, RF respiratory failure, LD liver disease, AKI acute kidney injury, CKD chronic kidney disease, WBC white blood cell, RBC red blood cell, TC total cholesterol, TG triglyceride, LDL low-density lipoprotein, HDL high-density lipoprotein, HbA1c hemoglobin A1c, Ucr urine creatinine, Scr serum creatinine, BUN blood urea nitrogen, LOS length of stay

aAKI was defined according to KDIGO guidelines as an increase in serum creatinine (Scr) by ≥ 0.3 mg/dL (≥ 26.5 μmol/L) from baseline within 48 h